SCHEMBL7985142

SCHEMBL7985142

CCO[C@H]1CC[C@@](CS)(C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)Nc2ccccc2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 19/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985143 1.00 MMP1 (1.00) MMP1
SCHEMBL7971597 0.97 MMP1 (1.00) MMP1
SCHEMBL7971594 0.97 MMP1 (1.00) MMP1
SCHEMBL7985712 0.94 MMP1 (1.00) MMP1
SCHEMBL7985711 0.94 MMP1 (1.00) MMP1
SCHEMBL8177659 0.92 MMP1 (0.84) MMP1
SCHEMBL8177663 0.92 MMP1 (0.84) MMP1
SCHEMBL7971538 0.91 MMP1 (0.86) MMP1
SCHEMBL7971536 0.91 MMP1 (0.86) MMP1
SCHEMBL7982810 0.91 MMP1 (1.00) MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201133-B1 FOR INHIBITING MATRIX-DEGRADING METALLOPROTEINASES IN MAMMALS, TREATING TNF ALPHA AND MATRIX METALLOPROTEINASE DEPENDENT DISEASES OR CONDITIONS, CANCER NOVARTIS AG (CH) 2001-03-13 US disclosed
US-6034136-A METALLOPROTEINASE INHIBITOR NOVARTIS AG (CH) 2000-03-07 US disclosed